World's Best Scientists 2026 revealed!
Shoji Nakamori

Shoji Nakamori

D-Index & Metrics

Medicine

D-Index
78
Citations
20427
World Ranking
18106
National Ranking
580

Overview

Shoji Nakamori is affiliated with Osaka University in Japan. Their research activity is primarily situated within the field of Medicine, with significant contributions across various subfields including Surgery, Oncology, Epidemiology, Endocrinology, and Pulmonary and Respiratory Medicine. Their scholarly output spans topics such as pancreatic and hepatic oncology research, neuroendocrine tumor research advances, cholangiocarcinoma and gallbladder cancer studies, pancreatitis pathology and treatment, esophageal and gastrointestinal pathology, colorectal cancer treatments and studies, and antibiotic resistance in bacteria.

Nakamori's recent publications demonstrate engagement with clinical oncology and gastrointestinal diseases. Key papers include:

  • "nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients" (2020, Cancer Medicine)
  • "A prolonged multispecies outbreak of IMP-6 carbapenemase-producing Enterobacterales due to horizontal transmission of the IncN plasmid" (2020, Scientific Reports)
  • "Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study" (2020, Journal of Hepato-Biliary-Pancreatic Sciences)
  • "Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106" (2020, Japanese Journal of Clinical Oncology)
  • "Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma" (2021, Clinical Journal of Gastroenterology)

Their work has been published in a variety of venues, with frequent appearances in the journal Pancreas alongside other journals such as Cancer Medicine, Scientific Reports, Journal of Hepato-Biliary-Pancreatic Sciences, and Japanese Journal of Clinical Oncology.

Nakamori collaborates often with several researchers, forming a network of frequent coauthors including:

  • Akira Fukutomi
  • Makoto Ueno
  • Takuji Okusaka
  • Junji Furuse
  • Tatsuya Ioka

Their research focus aligns heavily with pancreatic and hepatic oncology as well as neuroendocrine tumors, integrating clinical studies, surgical outcomes, and treatment evaluations. This multidisciplinary focus spans both cancer and gastrointestinal diseases, reflecting a broad scope that includes pathology and resistance mechanisms in bacteria.

Best Publications

  • Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

    Katsuhiko Uesaka;Narikazu Boku;Akira Fukutomi;Yukiyasu Okamura

  • Epithelial–mesenchymal transition in cancer development and its clinical significance

    Masaaki Iwatsuki;Koshi Mimori;Takehiko Yokobori;Hideshi Ishi

  • Increased Expression of Sialyl Lewisx Antigen Correlates with Poor Survival in Patients with Colorectal Carcinoma: Clinicopathological and Immunohistochemical Study

    Shoji Nakamori;Masao Kameyama;Shingi Imaoka;Hiroshi Furukawa

  • MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma

    Shoji Nakamori;David M. Ota;Karen R. Cleary;Keiro Shirotani

  • Genetic diagnosis of lymph-node metastasis in colorectal cancer.

    N. Hayashi;I. Ito;Y. Nakamura;A. Yanagisawa

  • Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.

    Shinji Yamamoto;Yasuhiko Tomita;Yoshihiko Hoshida;Takaya Morooka

  • Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

    Masato Sakon;Hiroaki Nagano;Keizo Dono;Shoji Nakamori

  • The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction

    Shinzaburo Noguchi;Tomohiko Aihara;Shoji Nakamori;Kazuyoshi Motomura

  • Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.

    Yubo Yang;Hiroaki Nagano;Hideo Ota;Osakuni Morimoto

  • Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.

    Motoi Kondo;Hirofumi Yamamoto;Hiroaki Nagano;Jiro Okami

  • Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas

    Jiro Okami;Hirofumi Yamamoto;Yoshiyuki Fujiwara;Masaki Tsujie

  • Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

    Shin Nakahira;Shoji Nakamori;Masanori Tsujie;Yuji Takahashi

  • Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

    C. Morizane;T. Okusaka;J. Mizusawa;H. Katayama

  • Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections

    Yasunari Fukuda;Kazuyoshi Yamamoto;Motohiro Hirao;Kazuhiro Nishikawa

  • Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy

    Yasunari Fukuda;Kazuyoshi Yamamoto;Motohiro Hirao;Kazuhiro Nishikawa

  • Overexpression of Small GTP-binding Protein RhoA Promotes Invasion of Tumor Cells

    Kiyoko Yoshioka;Shoji Nakamori;Kazuyuki Itoh

  • Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer.

    Kazuyoshi Yamamoto;Yukiko Nagatsuma;Yasunari Fukuda;Motohiro Hirao

  • Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

    Terumasa Yamada;Shoji Nakamori;Hiroki Ohzato;Satoshi Oshima

  • Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

    Yasuhiro Ito;Nariaki Matsuura;Masato Sakon;Eiji Miyoshi

  • Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system.

    Yoko Takahashi;Jun Ichi Hamada;Katsuhiko Murakawa;Minoru Takada

Frequent Co-Authors

Hiroaki Nagano
Hiroaki Nagano Osaka University
Morito Monden
Morito Monden Osaka University
Takuji Okusaka
Takuji Okusaka National Cancer Centre
Hirofumi Yamamoto
Hirofumi Yamamoto Osaka University
Osamu Ishikawa
Osamu Ishikawa Gunma University
Junji Furuse
Junji Furuse Kyorin University
Hidetoshi Eguchi
Hidetoshi Eguchi Osaka University
Takamichi Murakami
Takamichi Murakami Kobe University
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but looking for flexible online options, there are many reputable degrees and pathways to consider. Aspiring healthcare administrators can explore cahme accredited online mha programs, which offer high-quality, recognized training in a virtual format. These programs are ideal for those wanting to lead and manage in healthcare without the need for on-campus attendance.

Registered nurses aiming to advance can find online rn-bsn programs without clinicals, providing a convenient way to earn a bachelor’s degree without extra clinical requirements. For nurses ready to move into advanced practice or leadership, accelerated dnp programs help fast-track a Doctor of Nursing Practice degree.

For those concerned about the research component, there are also dnp programs without dissertation, allowing professionals to focus on practical impacts and leadership in nursing. Each option supports different career goals and offers flexible routes to advancement in the medical field.

Best Scientists Citing Shoji Nakamori

Trending Scientists